| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/27/2004 | EP1469877A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 10/27/2004 | EP1469870A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1469868A1 Kurkumin composition for the cure of large intestine polyps |
| 10/27/2004 | EP1469860A2 Anti-cancer combination and use thereof |
| 10/27/2004 | EP1469858A1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 10/27/2004 | EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis |
| 10/27/2004 | EP1469856A2 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 10/27/2004 | EP1469854A1 Condensed heterocyclic compounds |
| 10/27/2004 | EP1469847A1 Combinations comprising epothilones and anti-metabolites |
| 10/27/2004 | EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 10/27/2004 | EP1469842A2 Bicyclic cb2 cannabinoid receptor ligands |
| 10/27/2004 | EP1469835A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 10/27/2004 | EP1469809A2 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 10/27/2004 | EP1469769A2 Novel compositions and methods for cancer |
| 10/27/2004 | EP1387701B1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
| 10/27/2004 | EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 10/27/2004 | EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/27/2004 | EP1204407B1 Implantable active ingredient depot |
| 10/27/2004 | EP1165117B1 Use of interferon-beta in the manufacture of a medicament for the treatment of ewing's sarcoma and eoe |
| 10/27/2004 | EP1037629B1 Combination of a retinoic acid metabolism blocking agent and a tocophereol |
| 10/27/2004 | EP0960108B1 Matrix metalloproteinase inhibitors |
| 10/27/2004 | EP0918795B1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 10/27/2004 | EP0813544B1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 10/27/2004 | EP0807125B1 Monoclonal antibodies anti-cd6 for the treatment and diagnosis of psoriasis |
| 10/27/2004 | EP0763052B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 10/27/2004 | EP0759992B1 Human papilloma virus inhibition by a hairpin ribozyme |
| 10/27/2004 | CN1541335A EPF receptor assays, compounds and therapeutic compsns. |
| 10/27/2004 | CN1541277A Method of determing chemotherapeutic regimen based on glutachione-S-transferase pi expression |
| 10/27/2004 | CN1541269A Human protooncogene KG-zo and protein encoded therein |
| 10/27/2004 | CN1541226A Antibodes specific for CD44V6 |
| 10/27/2004 | CN1541224A Antagonistic anti-hTNFSF13b Human antibodies |
| 10/27/2004 | CN1541222A Antibodies to non-functional P 2 Chi 7 receptor diagnosis and treatment of cancers and other conditions |
| 10/27/2004 | CN1541220A 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 10/27/2004 | CN1541214A Novel compounds |
| 10/27/2004 | CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/27/2004 | CN1541201A Aliphatic amino-substituted demethoxylated hyporcrellins and their synthesis |
| 10/27/2004 | CN1541111A Mutant forms of cholera holotoxin as adjuvant |
| 10/27/2004 | CN1541109A Inhibitors of HER3 activity |
| 10/27/2004 | CN1541107A Growth factor complex |
| 10/27/2004 | CN1541106A Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases |
| 10/27/2004 | CN1541105A Combination therapies using vitamin B12 and interferon for treatment of viral, provliferative and inflammatory diseases |
| 10/27/2004 | CN1541102A Somatostain agonists |
| 10/27/2004 | CN1541098A Combination therapy for treatment of cancer |
| 10/27/2004 | CN1541097A 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 10/27/2004 | CN1541096A Compounds which mimic chemical and biological properties of discodermolide |
| 10/27/2004 | CN1539986A Method for extracting composite polysaccharide AVDS possessing anticarcinogenesis from 'mao renshen' and medical usage |
| 10/27/2004 | CN1539979A PGO of RNA1 carrier possessing labelling of green fluorescence protein and screening tag of resistance |
| 10/27/2004 | CN1539831A Taxad alkyl derivative and its prepn. process |
| 10/27/2004 | CN1539507A Method for preparing radioactive arsenic compound and usage for curing tumour |
| 10/27/2004 | CN1539502A Unique idiocratic innunization method for against cancer |
| 10/27/2004 | CN1539481A Method for preparing injection of oleum functus brucease |
| 10/27/2004 | CN1539469A Drug for treating cancer |
| 10/27/2004 | CN1539458A Chinese materia medica preparation made from gen-seng and astragalus root for strengthening the body resistance and anti cancer as well as producing method |
| 10/27/2004 | CN1539455A Medical combination possessing effect for turning cancer off and rejuvenation |
| 10/27/2004 | CN1539419A Compound preparation of reveratrol and application |
| 10/27/2004 | CN1539412A New usage of (R)-flrubiprofen in area of drug efficacy activity |
| 10/27/2004 | CN1539411A Dispersion tablet of Tamoxifen(Nolvedox) of cedrat acid as well as preparationmethod and usage |
| 10/27/2004 | CN1539407A Solid powder preparaton from liposome of Hypocrellin and producing method |
| 10/27/2004 | CN1173033C Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 10/27/2004 | CN1172956C Mutational human gene nucleotide sequence coded polypeptide and its applications |
| 10/27/2004 | CN1172952C Mannosan peptide and its prepn and use |
| 10/27/2004 | CN1172945C Synthesis process of antineoplastic drug etoposite |
| 10/27/2004 | CN1172943C Organic arsine compounds with the function of inducing cancer cell to die and their synthesis process |
| 10/27/2004 | CN1172932C Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase |
| 10/27/2004 | CN1172929C Substituted indoles for modulating NFKB activity |
| 10/27/2004 | CN1172918C Isothizole derivatives useful anticancer agents |
| 10/27/2004 | CN1172914C Gutarimide compound S632A3 and its prepn and application in preparing medicine for treating viral infection and tumor |
| 10/27/2004 | CN1172911C Phtalimido arylpiperazines as alpha IA receptor antagonists useful in the treatment of benign prostatic hyperplasia |
| 10/27/2004 | CN1172718C Dendritic cell stimulatory factor |
| 10/27/2004 | CN1172713C Chinese patent medicine for treating cancer |
| 10/27/2004 | CN1172692C Powdered medicine for treating tumor and its preparing process |
| 10/27/2004 | CN1172672C Alpha-ketoamide multicatalytic protease inhibitors |
| 10/27/2004 | CN1172668C Use of chelerythrine in prepn. of medicine |
| 10/26/2004 | US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 10/26/2004 | US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof |
| 10/26/2004 | US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 10/26/2004 | US6809189 Apoptin-associating protein |
| 10/26/2004 | US6809178 Polypeptide for use in the treatment of addison's disease |
| 10/26/2004 | US6809106 Antiproliferation agents; such as 4-(2-methoxyphenoxy)-anilino-3-chloro-6,7-dimethoxyquinoline |
| 10/26/2004 | US6809103 E-ring expanded camptothecin derivatives |
| 10/26/2004 | US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis |
| 10/26/2004 | US6809100 Hydroxamic acid derivatives |
| 10/26/2004 | US6809099 Saframycins, analogues and uses thereof |
| 10/26/2004 | US6809098 Compounds |
| 10/26/2004 | US6809096 Such as 11-methoxy-7h-pyrido(4,3,2-de)(1,7)phenanthroline-7-one; antitumor agents |
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/26/2004 | US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors |
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808930 Labelling reagent; can be used in diagnosis and therapy of cancer/tumors; detection of penetration of nucleus susceptible to alpha-lactalbumin (mal) |
| 10/26/2004 | US6808916 Method of extracting virus from cell culture |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | US6808878 Genes from the 20Q13 amplicon and their uses |
| 10/26/2004 | US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal |
| 10/26/2004 | US6808705 For suppressing the proliferation of cancer cells |
| 10/26/2004 | CA2328060C Gene any-rf, dormancy-control substance and method for preparing the same as well as cell-control agent for biological cells |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2266759C 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 10/26/2004 | CA2263888C Methods and compositions for the detection of cervical cancer |
| 10/26/2004 | CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation |